HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for fighting genetic cholesterol disorder
Disease control CompletedThis study tested whether a new drug called SHR-1918 could lower bad cholesterol in people with a rare, severe genetic condition called homozygous familial hypercholesterolemia. Fifty-five participants received either the drug or a placebo for 24 weeks while continuing their usua…
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial targets stubborn genetic cholesterol
Disease control CompletedThis study tested an experimental drug called SHR-1918 in 26 patients with a rare, inherited form of very high cholesterol. The goal was to see if the drug could safely lower their 'bad' LDL cholesterol levels over 12 weeks. All participants received the drug while continuing the…
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE2 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC